Tag: atrial fibrillation

1. Landiolol administration resulted in significantly more patients achieving target heart rates of 60-94 following sepsis-related tachyarrhythmia and was also associated with significantly reduced incidence of new onset arrhythmia Evidence Rating: 1 (Excellent) Sepsis associated tachyarrhythmias and atrial fibrillation are significant causes of mortality, with as many as a third of patients...
1. Landiolol administration resulted in significantly more patients achieving target heart rates of 60-94 following sepsis-related tachyarrhythmia and was also associated with significantly reduced incidence of new onset arrhythmia Evidence Rating: 1 (Excellent) Sepsis associated tachyarrhythmias and atrial fibrillation are significant causes of mortality, with as many as a third of patients...
Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial 1. Patients receiving landiolol were more likely to achieve target heart rates of 60-94 following sepsis-related tachyarrhythmia and had significantly reduced incidence of new onset arrhythmia Evidence Rating: 1...
1. Direct oral anticoagulants, specifically apixaban, were associated with lower risk of fracture in patients with atrial fibrillation compared to warfarin. Evidence Rating Level: 2 (Good) Warfarin is commonly used to prevent cardioembolic events in individuals with atrial fibrillation (AF). The impact of warfarin treatment on bone health is clinically...
Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation 1. Direct oral anticoagulants, specifically apixaban, were associated with lower risk of fracture in patients with atrial fibrillation compared to warfarin. Evidence Rating Level: 2 (Good) Warfarin is commonly used to prevent cardioembolic events in individuals with atrial fibrillation...
1. In this retrospective observational study, direct oral anticoagulant use for atrial fibrillation in patients with mitral stenosis was linked with decreased mortality and fewer thromboembolic events compared to warfarin.  2. There was also a non-significant trend towards fewer episodes of intracranial hemorrhage with direct oral anticoagulant use. Evidence Rating Level:...
1. Significant variation in benefit per person was observed depending on stroke rates utilized in current guidelines. 2. The greatest population benefit was shown when using stroke rates from the Danish National Patient Registry. Evidence Rating Level: 2 (Good) Study Rundown: Patients with atrial fibrillation (AF) are often treated with oral anticoagulation,...
1. In this randomized controlled trial, patients who received immediate atrial fibrillation (AF) monitoring with a new, wearable EKG were more likely to have their AF diagnosed compared to the delayed monitoring group. 2.Participants in the active monitoring group had a higher rate of initiation of anticoagulant therapy specifically for...
1. In this meta-analysis, addition of vasopressin to catecholamine vasopressors was associated with a lower risk of atrial fibrillation when compared to catecholamine monotherapy. 2. While there was decreased mortality with vasopressin plus catecholamines, this difference was not seen when restricting analysis to studies with a low risk of bias. Evidence...
1. Compared to medical therapy alone, catheter ablation of atrial fibrillation in patients with heart failure reduced the risk of all-cause mortality and hospitalization. 2. Procedural complications of catheter ablation included pericardial effusion and severe bleeding. Evidence Rating Level: 1 (Excellent) Study Rundown: Atrial fibrillation is a common comorbidity that worsens outcomes...